专家访谈
|

<International Diabetes>: Dr. Whitehouse, so looking back on the diabetes therapy history 50 years ago, what is the most impressive....
|

<International Diabetes>: So, Professor Brand-Miller, so talking about the pathogenesis, what is the benefit of low glycemic index food f....
|

<International Diabetes>: So which factors will influence the effectiveness of insulin therapy?
Dr. Harris: Right. So one of the big c....
|

《国际糖尿病》:夏医生您好,先请您介绍一下自己。
我来自中国中医科学院西苑医院内分泌科,我叫夏城东,非常高兴也非常荣幸能有机会参加《国际糖尿病》编辑部主办的2015年关于国际糖尿病热点问题的讨论。我能成为其幸运读者之一,由《国际糖尿病》编辑部支持前往波士顿参加第....
|

<International Diabetes>:So, Dr. Scherer, in recent years, many studies focused on brown adipocytes. So what do you think of the role of....
|

<International Diabetes>: Dr. Seaquist, the type 2 diabetes (T2D) is strongly associated with cognitive impairment, would you please int....
|

<International Diabetes>: Dr. Dagogo-Jack, as the president of the ADA, are there any features of this scientific meeting this year you w....
|

《国际糖尿病》: 刘博士,恭喜您应邀在ADA2015大会做口头报告,您可否和大家介绍一下自己并且跟我们分享一下报告内容?
刘芳博士:好的。大家好, 我是上海第六人民医院内分泌代谢科的刘芳,非常荣幸在ADA大会做口头报告。我参加的session是每年ADA糖尿病足....
|

《国际糖尿病》:如果将中国、印度、中东、太平洋和印度洋和巴西等糖尿病高患病率地区的流行病学做一个横向对比,它们有何共同点和差异呢?又带给我们中国糖尿病医生怎样的思考?
翁建平教授:这个问题非常有意思。ADA为什么把这些国家放在一起?因为总体而言,它们均来自糖尿病....
|

<International Diabetes>: So in your title “We are Winning the Battle, but Losing the War,” what the real meaning of this?
&....
|